Search results
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 11 hours agoRhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families living with rare neuroendocrine ...
WPD: Mental health calls climb
The Missourian· 3 days agoWashington police say responding to mental health crises has become a larger part of their job in the last decade, and their level of crisis training has...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 23 hours agoCognition Therapeutics, Inc. (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical stage company developing drugs that treat neurodegenerative disorders, today announced that the company ...
Santé: Giving Back for Kidney Disease Fundraiser Returns to Baltimore May 8 - The Baltimore Times
Baltimore Times· 4 days agoWhen Vaunita Goodman experienced deep pain in her back area and flu-like symptoms in 2016, she was...
Tri-State clinics and trials help patients with long COVID
Local 12 Cincinnati· 7 days agoThere are several new clinical trials in the works for long COVID and infectious disease specialists...
Electronic System Slashes Antibiotic Use
Medscape· 6 days agoThe randomized control trials included more than 200,000 adult patients with non–life threatening pneumonia or urinary tract infections (UTIs) in 59...
Long flu season winds down in US
San Francisco Chronicle· 4 days agoThe U.S. flu season appears to be over. Last week, for the third straight week, medical visits for flu-like illnesses dipped below the threshold for...
Long flu season winds down in US
Odessa American· 4 days agoNEW YORK The U.S. flu season appears to be over. Last week, for the third straight week, medical visits for flu-like illnesses dipped below the threshold...
Long flu season winds down in US
McComb Enterprise-Journal· 4 days agoA sign for flu vaccination is displayed outside of a grocery store in Glenview, Ill., Thursday, Feb. 15, 2024. On Friday, April 26, 2024, the Centers for Disease Control and Prevention said ...
EMA Approves Factor VIII Deficiency Clotting Drug
Medscape· 4 days agoEuropean Union marketing authorization recommended for Altuvoct for hemophilia A caused by factor VIII deficiency.
